Oxford/AstraZeneca COVID-19 vaccine 'could substantially slow virus spread', study suggests

Researchers have reported the first evidence that a COVID-19 vaccine could reduce transmission of the virus.

by Chloe Harman
Primary analysis of the Oxford/AstraZeneca COVID-19 VACCINE trials has confirmed the vaccine provides 100% protection against severe disease, hospitalisation and death. | GETTY IMAGES
Primary analysis of the Oxford/AstraZeneca COVID-19 VACCINE trials has confirmed the vaccine provides 100% protection against severe disease, hospitalisation and death. | GETTY IMAGES

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package